Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amanda Zaman"'
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
ObjectivesFecal microbiota transplantation (FMT) is a recommended therapy for recurrent Clostridioides difficile infection and is being investigated as a potential therapy for dozens of microbiota-mediated indications. Stool banks centralize FMT dono
Externí odkaz:
https://doaj.org/article/7076e7fd5c5c4877973e8c2f55134ef5
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology
ObjectivesFecal microbiota transplantation (FMT) is a recommended therapy for recurrent Clostridioides difficile infection and is being investigated as a potential therapy for dozens of microbiota-mediated indications. Stool banks centralize FMT dono
ObjectivesFecal microbiota transplantation (FMT) is a recommended therapy for recurrentClostridioides difficileinfection and is being investigated as a potential therapy for dozens of microbiome-mediated indications. Stool banks centralize FMT donor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9829b90a80a6395750a0acb37da892f0
https://doi.org/10.1101/2020.09.03.20187583
https://doi.org/10.1101/2020.09.03.20187583
The potential for transmission of SARS-CoV-2 shed in stool via fecal microbiota transplantation is not yet known, and the effectiveness of various testing strategies to prevent FMT-based transmission has also not yet been quantified. Here we use a ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f077046663bc4a505e518348d5a6bb6f
https://doi.org/10.1101/2020.06.24.169094
https://doi.org/10.1101/2020.06.24.169094
Publikováno v:
The Lancet Infectious Diseases. 21:454-455
Publikováno v:
Infection Control & Hospital Epidemiology. 41:s85-s86
Background: Fecal microbiota transplantation (FMT) has emerged as standard of care for Clostridioides difficile not responsive to antibiotic therapy. Rigorous screening of healthy donors is critical to patient safety. As part of routine donor evaluat